{"entity":{"type":"insider","cik":"0002003514","url":"/insider/0002003514","json_url":"/insider/0002003514.json","name":"Exploration Capital, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":19,"first":"2023-12-06","last":"2024-06-11","span_basis":"filed_date"},"name_variants":[{"name":"Exploration Capital, LLC","source":"filing","n_filings":19,"first_seen":"2023-12-06","last_seen":"2024-06-11"}],"transactions":[{"id":2270060,"accession":"0001213900-24-051866","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-051866","line_url":"/filing/0001213900-24-051866#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":86185.0,"shares_display":"86,185","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":81013.9,"total_display":"81,013.90","total_whole":"81,014","shares_owned_after":1739412.0,"shares_owned_after_display":"1,739,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-10","filed_date":"2024-06-11","scope":"insider"},{"id":2270056,"accession":"0001213900-24-051866","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-051866","line_url":"/filing/0001213900-24-051866#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":319315.0,"shares_display":"319,315","price_per_share":0.94,"price_display":"0.94","price_state":"stated","total_value":300156.1,"total_display":"300,156.10","total_whole":"300,156","shares_owned_after":1653227.0,"shares_owned_after_display":"1,653,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-11","scope":"insider"},{"id":2794810,"accession":"0001213900-24-048558","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-048558","line_url":"/filing/0001213900-24-048558#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":516.0,"shares_display":"516","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":459.24,"total_display":"459.24","total_whole":"459","shares_owned_after":1333912.0,"shares_owned_after_display":"1,333,912","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-05-31","scope":"insider"},{"id":2794801,"accession":"0001213900-24-048558","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-048558","line_url":"/filing/0001213900-24-048558#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9838.0,"shares_display":"9,838","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":9050.96,"total_display":"9,050.96","total_whole":"9,051","shares_owned_after":1333396.0,"shares_owned_after_display":"1,333,396","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-05-31","scope":"insider"},{"id":2794795,"accession":"0001213900-24-048558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-048558","line_url":"/filing/0001213900-24-048558#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80.0,"shares_display":"80","price_per_share":0.87,"price_display":"0.87","price_state":"stated","total_value":69.6,"total_display":"69.60","total_whole":"70","shares_owned_after":1323558.0,"shares_owned_after_display":"1,323,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-31","scope":"insider"},{"id":2473862,"accession":"0001213900-24-046344","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-046344","line_url":"/filing/0001213900-24-046344#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15627.0,"shares_display":"15,627","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":14220.57,"total_display":"14,220.57","total_whole":"14,221","shares_owned_after":1323478.0,"shares_owned_after_display":"1,323,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-23","filed_date":"2024-05-23","scope":"insider"},{"id":2473854,"accession":"0001213900-24-046344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-046344","line_url":"/filing/0001213900-24-046344#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":383.0,"shares_display":"383","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":340.87,"total_display":"340.87","total_whole":"341","shares_owned_after":1307851.0,"shares_owned_after_display":"1,307,851","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-22","filed_date":"2024-05-23","scope":"insider"},{"id":2473848,"accession":"0001213900-24-046344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-046344","line_url":"/filing/0001213900-24-046344#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6879.0,"shares_display":"6,879","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":6259.89,"total_display":"6,259.89","total_whole":"6,260","shares_owned_after":1307468.0,"shares_owned_after_display":"1,307,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-23","scope":"insider"},{"id":2473834,"accession":"0001213900-24-045315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-045315","line_url":"/filing/0001213900-24-045315#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":797.0,"shares_display":"797","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":725.27,"total_display":"725.27","total_whole":"725","shares_owned_after":1300589.0,"shares_owned_after_display":"1,300,589","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-20","scope":"insider"},{"id":2473827,"accession":"0001213900-24-045315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-045315","line_url":"/filing/0001213900-24-045315#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":73768.0,"shares_display":"73,768","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":67866.56,"total_display":"67,866.56","total_whole":"67,867","shares_owned_after":1299792.0,"shares_owned_after_display":"1,299,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-20","scope":"insider"},{"id":2547994,"accession":"0001213900-24-040869","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-040869","line_url":"/filing/0001213900-24-040869#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":320.0,"shares_display":"320","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":284.8,"total_display":"284.80","total_whole":"285","shares_owned_after":1226024.0,"shares_owned_after_display":"1,226,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-08","scope":"insider"},{"id":2248624,"accession":"0001213900-24-039764","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-039764","line_url":"/filing/0001213900-24-039764#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":324.0,"shares_display":"324","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":294.84,"total_display":"294.84","total_whole":"295","shares_owned_after":1225723.0,"shares_owned_after_display":"1,225,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-03","filed_date":"2024-05-03","scope":"insider"},{"id":2248619,"accession":"0001213900-24-039764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-039764","line_url":"/filing/0001213900-24-039764#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2222.0,"shares_display":"2,222","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":2022.02,"total_display":"2,022.02","total_whole":"2,022","shares_owned_after":1225380.0,"shares_owned_after_display":"1,225,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2248612,"accession":"0001213900-24-039764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-039764","line_url":"/filing/0001213900-24-039764#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":162351.0,"shares_display":"162,351","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":149362.92,"total_display":"149,362.92","total_whole":"149,363","shares_owned_after":1223158.0,"shares_owned_after_display":"1,223,158","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-01","filed_date":"2024-05-03","scope":"insider"},{"id":2547971,"accession":"0001213900-24-035431","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-035431","line_url":"/filing/0001213900-24-035431#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":343.0,"shares_display":"343","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":312.13,"total_display":"312.13","total_whole":"312","shares_owned_after":1060807.0,"shares_owned_after_display":"1,060,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-23","filed_date":"2024-04-23","scope":"insider"},{"id":2547965,"accession":"0001213900-24-035431","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-035431","line_url":"/filing/0001213900-24-035431#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16908.0,"shares_display":"16,908","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":15217.2,"total_display":"15,217.20","total_whole":"15,217","shares_owned_after":1060464.0,"shares_owned_after_display":"1,060,464","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-22","filed_date":"2024-04-23","scope":"insider"},{"id":2547960,"accession":"0001213900-24-035431","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-035431","line_url":"/filing/0001213900-24-035431#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4277.0,"shares_display":"4,277","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":3892.07,"total_display":"3,892.07","total_whole":"3,892","shares_owned_after":1043556.0,"shares_owned_after_display":"1,043,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-19","filed_date":"2024-04-23","scope":"insider"},{"id":2992921,"accession":"0001213900-24-032240","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-032240","line_url":"/filing/0001213900-24-032240#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":880.0,"total_display":"880.00","total_whole":"880","shares_owned_after":1039279.0,"shares_owned_after_display":"1,039,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-10","filed_date":"2024-04-11","scope":"insider"},{"id":2992917,"accession":"0001213900-24-032240","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-032240","line_url":"/filing/0001213900-24-032240#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2188.0,"shares_display":"2,188","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":1925.44,"total_display":"1,925.44","total_whole":"1,925","shares_owned_after":1038279.0,"shares_owned_after_display":"1,038,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-09","filed_date":"2024-04-11","scope":"insider"},{"id":2852519,"accession":"0001213900-24-030877","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-030877","line_url":"/filing/0001213900-24-030877#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1050.0,"shares_display":"1,050","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":955.5,"total_display":"955.50","total_whole":"956","shares_owned_after":1036091.0,"shares_owned_after_display":"1,036,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-05","filed_date":"2024-04-05","scope":"insider"},{"id":2852514,"accession":"0001213900-24-030877","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-030877","line_url":"/filing/0001213900-24-030877#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3400.0,"shares_display":"3,400","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":3094.0,"total_display":"3,094.00","total_whole":"3,094","shares_owned_after":1035041.0,"shares_owned_after_display":"1,035,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-04","filed_date":"2024-04-05","scope":"insider"},{"id":2852507,"accession":"0001213900-24-030877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-030877","line_url":"/filing/0001213900-24-030877#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12928.0,"shares_display":"12,928","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":11764.48,"total_display":"11,764.48","total_whole":"11,764","shares_owned_after":1031641.0,"shares_owned_after_display":"1,031,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-05","scope":"insider"},{"id":2641603,"accession":"0001213900-24-028916","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-028916","line_url":"/filing/0001213900-24-028916#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":354.0,"shares_display":"354","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":315.06,"total_display":"315.06","total_whole":"315","shares_owned_after":1018713.0,"shares_owned_after_display":"1,018,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-01","scope":"insider"},{"id":2641599,"accession":"0001213900-24-028916","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-028916","line_url":"/filing/0001213900-24-028916#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2586.0,"shares_display":"2,586","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":2327.4,"total_display":"2,327.40","total_whole":"2,327","shares_owned_after":1018359.0,"shares_owned_after_display":"1,018,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-28","filed_date":"2024-04-01","scope":"insider"},{"id":2641591,"accession":"0001213900-24-028916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-028916","line_url":"/filing/0001213900-24-028916#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":51634.0,"shares_display":"51,634","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":46470.6,"total_display":"46,470.60","total_whole":"46,471","shares_owned_after":1015773.0,"shares_owned_after_display":"1,015,773","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-04-01","scope":"insider"},{"id":2591666,"accession":"0001213900-24-024839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-024839","line_url":"/filing/0001213900-24-024839#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":287.0,"shares_display":"287","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":261.17,"total_display":"261.17","total_whole":"261","shares_owned_after":964139.0,"shares_owned_after_display":"964,139","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-20","filed_date":"2024-03-21","scope":"insider"},{"id":2591654,"accession":"0001213900-24-024839","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-024839","line_url":"/filing/0001213900-24-024839#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10.0,"shares_display":"10","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":9.0,"total_display":"9.00","total_whole":"9","shares_owned_after":963852.0,"shares_owned_after_display":"963,852","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-21","scope":"insider"},{"id":2060361,"accession":"0001213900-24-022246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-022246","line_url":"/filing/0001213900-24-022246#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9126.0,"shares_display":"9,126","price_per_share":0.92,"price_display":"0.92","price_state":"stated","total_value":8395.92,"total_display":"8,395.92","total_whole":"8,396","shares_owned_after":963842.0,"shares_owned_after_display":"963,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-13","scope":"insider"},{"id":2060359,"accession":"0001213900-24-022246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-022246","line_url":"/filing/0001213900-24-022246#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":1365.0,"total_display":"1,365.00","total_whole":"1,365","shares_owned_after":954716.0,"shares_owned_after_display":"954,716","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-13","scope":"insider"},{"id":2060340,"accession":"0001213900-24-022246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-022246","line_url":"/filing/0001213900-24-022246#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5703.0,"shares_display":"5,703","price_per_share":0.91,"price_display":"0.91","price_state":"stated","total_value":5189.73,"total_display":"5,189.73","total_whole":"5,190","shares_owned_after":953216.0,"shares_owned_after_display":"953,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-13","scope":"insider"},{"id":3077552,"accession":"0001213900-24-018112","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-018112","line_url":"/filing/0001213900-24-018112#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20109.0,"shares_display":"20,109","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":18098.1,"total_display":"18,098.10","total_whole":"18,098","shares_owned_after":947513.0,"shares_owned_after_display":"947,513","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-28","scope":"insider"},{"id":2213979,"accession":"0001213900-24-016223","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-016223","line_url":"/filing/0001213900-24-016223#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5175.0,"shares_display":"5,175","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":4657.5,"total_display":"4,657.50","total_whole":"4,658","shares_owned_after":927404.0,"shares_owned_after_display":"927,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-22","filed_date":"2024-02-22","scope":"insider"},{"id":2213977,"accession":"0001213900-24-016223","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-016223","line_url":"/filing/0001213900-24-016223#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22278.0,"shares_display":"22,278","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":20050.2,"total_display":"20,050.20","total_whole":"20,050","shares_owned_after":922229.0,"shares_owned_after_display":"922,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-21","filed_date":"2024-02-22","scope":"insider"},{"id":2213969,"accession":"0001213900-24-016223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-016223","line_url":"/filing/0001213900-24-016223#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49951.0,"shares_display":"49,951","price_per_share":0.88,"price_display":"0.88","price_state":"stated","total_value":43956.88,"total_display":"43,956.88","total_whole":"43,957","shares_owned_after":899951.0,"shares_owned_after_display":"899,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-20","filed_date":"2024-02-22","scope":"insider"},{"id":2269793,"accession":"0001213900-24-004190","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-004190","line_url":"/filing/0001213900-24-004190#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9038.0,"shares_display":"9,038","price_per_share":0.99,"price_display":"0.99","price_state":"stated","total_value":8947.62,"total_display":"8,947.62","total_whole":"8,948","shares_owned_after":850000.0,"shares_owned_after_display":"850,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-17","filed_date":"2024-01-17","scope":"insider"},{"id":2269788,"accession":"0001213900-24-004190","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-004190","line_url":"/filing/0001213900-24-004190#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10958.0,"shares_display":"10,958","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":10738.84,"total_display":"10,738.84","total_whole":"10,739","shares_owned_after":840962.0,"shares_owned_after_display":"840,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-17","scope":"insider"},{"id":3132348,"accession":"0001213900-24-003009","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-24-003009","line_url":"/filing/0001213900-24-003009#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3839.0,"shares_display":"3,839","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":3762.22,"total_display":"3,762.22","total_whole":"3,762","shares_owned_after":830004.0,"shares_owned_after_display":"830,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-11","filed_date":"2024-01-11","scope":"insider"},{"id":3132344,"accession":"0001213900-24-003009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-003009","line_url":"/filing/0001213900-24-003009#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9646.0,"shares_display":"9,646","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":9453.08,"total_display":"9,453.08","total_whole":"9,453","shares_owned_after":826165.0,"shares_owned_after_display":"826,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-11","scope":"insider"},{"id":3132338,"accession":"0001213900-24-003009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-003009","line_url":"/filing/0001213900-24-003009#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":38017.0,"shares_display":"38,017","price_per_share":0.98,"price_display":"0.98","price_state":"stated","total_value":37256.66,"total_display":"37,256.66","total_whole":"37,257","shares_owned_after":816519.0,"shares_owned_after_display":"816,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider"},{"id":2092961,"accession":"0001213900-24-001658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-24-001658","line_url":"/filing/0001213900-24-001658#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54625.0,"shares_display":"54,625","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":49162.5,"total_display":"49,162.50","total_whole":"49,163","shares_owned_after":778502.0,"shares_owned_after_display":"778,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":2092960,"accession":"0001213900-24-001658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-001658","line_url":"/filing/0001213900-24-001658#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23877.0,"shares_display":"23,877","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":21250.53,"total_display":"21,250.53","total_whole":"21,251","shares_owned_after":723877.0,"shares_owned_after_display":"723,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":7823698,"accession":"0001213900-23-097429","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-097429","line_url":"/filing/0001213900-23-097429#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":"0002003514","owner_name":"Exploration Capital, LLC","owner_display_name":"Exploration Capital, LLC","owner_url":"/insider/0002003514","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47000.0,"shares_display":"47,000","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":39480.0,"total_display":"39,480.00","total_whole":"39,480","shares_owned_after":47000.0,"shares_owned_after_display":"47,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-20","filed_date":"2023-12-20","scope":"insider"},{"id":7837426,"accession":"0001213900-23-093858","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001213900-23-093858","line_url":"/filing/0001213900-23-093858#line-3","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Exploration Capital Fund, LP; Exploration Capital General Partner, LLC; Exploration Capital, LLC","owner_display_name":"Exploration Capital Fund, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17233.0,"shares_display":"17,233","price_per_share":0.9,"price_display":"0.90","price_state":"stated","total_value":15509.7,"total_display":"15,509.70","total_whole":"15,510","shares_owned_after":700000.0,"shares_owned_after_display":"700,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-06","scope":"insider"},{"id":7837424,"accession":"0001213900-23-093858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001213900-23-093858","line_url":"/filing/0001213900-23-093858#line-2","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Exploration Capital Fund, LP; Exploration Capital General Partner, LLC; Exploration Capital, LLC","owner_display_name":"Exploration Capital Fund, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5188.0,"shares_display":"5,188","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":4409.8,"total_display":"4,409.80","total_whole":"4,410","shares_owned_after":682767.0,"shares_owned_after_display":"682,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":7837421,"accession":"0001213900-23-093858","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-093858","line_url":"/filing/0001213900-23-093858#line-1","is_derivative":false,"issuer_cik":"0000819050","issuer_name":"Fresh Tracks Therapeutics, Inc.","issuer_ticker":"FRTX","issuer_name_source":null,"issuer_url":"/issuer/0000819050","owner_cik":null,"owner_name":"Exploration Capital Fund, LP; Exploration Capital General Partner, LLC; Exploration Capital, LLC","owner_display_name":"Exploration Capital Fund, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7579.0,"shares_display":"7,579","price_per_share":0.85,"price_display":"0.85","price_state":"stated","total_value":6442.15,"total_display":"6,442.15","total_whole":"6,442","shares_owned_after":677579.0,"shares_owned_after_display":"677,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-04","filed_date":"2023-12-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":42,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000819050","name":"Fresh Tracks Therapeutics, Inc.","url":"/issuer/0000819050","role":"Ten percent owner","n_filings":19,"first_seen":"2023-12-06","last_seen":"2024-06-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0002003514","retrieved_at":"2026-08-24T06:02:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}